James V. Cassella

2.4k total citations
62 papers, 1.8k citations indexed

About

James V. Cassella is a scholar working on Cellular and Molecular Neuroscience, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, James V. Cassella has authored 62 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cellular and Molecular Neuroscience, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in James V. Cassella's work include Inhalation and Respiratory Drug Delivery (16 papers), Neuroscience and Neuropharmacology Research (10 papers) and Healthcare Decision-Making and Restraints (8 papers). James V. Cassella is often cited by papers focused on Inhalation and Respiratory Drug Delivery (16 papers), Neuroscience and Neuropharmacology Research (10 papers) and Healthcare Decision-Making and Restraints (8 papers). James V. Cassella collaborates with scholars based in United States, France and Hungary. James V. Cassella's co-authors include Michael T. Davis, John H. Kehne, Daniel A. Spyker, M. Davis, Robert N. Leaton, Diane C. Hoffman, Hilary Donovan, George S. Borszcz, Patrik Munzar and Robert Fishman and has published in prestigious journals such as Neurology, Brain Research and Neuroscience & Biobehavioral Reviews.

In The Last Decade

James V. Cassella

61 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James V. Cassella United States	26	676	454	378	296	279	62	1.8k
Ertan Tezcan Türkiye	31	219 0.3×	240 0.5×	914 2.4×	673 2.3×	167 0.6×	54	2.4k
Louise R. Levine United States	17	673 1.0×	386 0.9×	461 1.2×	283 1.0×	394 1.4×	29	1.7k
David E. Adson United States	18	256 0.4×	279 0.6×	501 1.3×	736 2.5×	99 0.4×	30	1.7k
Joseph Thavundayil Canada	21	335 0.5×	159 0.4×	385 1.0×	161 0.5×	166 0.6×	47	1.3k
Toshihito Suzuki Japan	27	463 0.7×	272 0.6×	438 1.2×	232 0.8×	416 1.5×	96	1.9k
Daniela Eser Germany	30	561 0.8×	222 0.5×	378 1.0×	151 0.5×	401 1.4×	73	2.3k
Bahman Salehi Iran	20	167 0.2×	151 0.3×	589 1.6×	197 0.7×	185 0.7×	72	1.5k
Maria Antonietta De Salvia Italy	24	343 0.5×	309 0.7×	138 0.4×	74 0.3×	273 1.0×	73	1.6k
Giovanna Flore Italy	23	1000 1.5×	382 0.8×	169 0.4×	62 0.2×	418 1.5×	41	1.7k

Countries citing papers authored by James V. Cassella

Since Specialization

Citations

This map shows the geographic impact of James V. Cassella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James V. Cassella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James V. Cassella more than expected).

Fields of papers citing papers by James V. Cassella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James V. Cassella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James V. Cassella. The network helps show where James V. Cassella may publish in the future.

Co-authorship network of co-authors of James V. Cassella

This figure shows the co-authorship network connecting the top 25 collaborators of James V. Cassella. A scholar is included among the top collaborators of James V. Cassella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James V. Cassella. James V. Cassella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kempers, Steven, Natasha Atanaskova Mesinkovska, Paradi Mirmirani, et al.. (2025). 62823 Optimization of deuruxolitinib dosing in adult patients with alopecia areata: Results from a randomized, parallel-group, multicenter, Phase 2 trial. Journal of the American Academy of Dermatology. 93(3). AB260–AB260. 2 indexed citations

Tsianakas, Athanasios, Thierry Passeron, Nina Magnolo, et al.. (2025). Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial. Journal of the American Academy of Dermatology. 94(4). 1134–1143.

Senna, Maryanne M., et al.. (2024). 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials. Journal of the American Academy of Dermatology. 91(3). AB39–AB39. 2 indexed citations

Senna, Maryanne M., Natasha Atanaskova Mesinkovska, Charles Lynde, et al.. (2024). Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1). Journal of the American Academy of Dermatology. 91(5). 880–888. 33 indexed citations

Senna, Maryanne M., et al.. (2023). 41701 Efficacy of the Oral JAK1/JAK2 Inhibitor CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata: Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 Phase 3 Trial. Journal of the American Academy of Dermatology. 89(3). AB43–AB43. 1 indexed citations

French, Jacqueline A., Robert Wechsler, Michael Gelfand, et al.. (2019). Inhaled alprazolam rapidly suppresses epileptic activity in photosensitive participants. Epilepsia. 60(8). 1602–1609. 35 indexed citations

Uttamsingh, Vinita, C.J. Hamilton, Ara M. Aslanian, et al.. (2018). 1060 JAK inhibitor CTP-543: Modeled exposure-response profile suggests improved therapeutic window. Journal of Investigative Dermatology. 138(5). S180–S180. 1 indexed citations

French, Jacqueline A., Daniel Friedman, Robert Wechsler, et al.. (2017). Inhaled Alprazolam, a Potential Rescue Medication, Works Rapidly in Patients with Photosensitive Epilepsy (P6.236). Neurology. 88(16_supplement). 3 indexed citations

Uddin, Nizam, et al.. (2016). WS13.6 CTP-656 tablet confirmed superiority of pharmacokinetic profile relative to Kalydeco ® in Phase I clinical studies. Journal of Cystic Fibrosis. 15. S22–S22. 8 indexed citations

10.

Spyker, Daniel A., Robert Riesenberg, & James V. Cassella. (2015). Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens. The Journal of Clinical Pharmacology. 55(9). 985–994. 13 indexed citations

11.

Gross, Nicholas J., Leon S. Greos, Eli O. Meltzer, et al.. (2014). Safety and Tolerability of Inhaled Loxapine in Subjects with Asthma and Chronic Obstructive Pulmonary Disease—Two Randomized Controlled Trials. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 27(6). 478–487. 19 indexed citations

12.

Spyker, Daniel A., et al.. (2013). Loxapine delivered as a thermally generated aerosol does not prolong QTc in a thorough QT/QTc study in healthy subjects. The Journal of Clinical Pharmacology. 54(6). 665–674. 21 indexed citations

13.

Avram, Michael J., Daniel A. Spyker, John H. Kehne, & James V. Cassella. (2012). The Pharmacokinetics and Pharmacodynamics of Zaleplon Delivered as a Thermally Generated Aerosol in a Single Breath to Volunteers. The Journal of Clinical Pharmacology. 53(2). 140–150. 3 indexed citations

14.

Lesem, Michael D., Tram Tran-Johnson, Robert Riesenberg, et al.. (2011). Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. The British Journal of Psychiatry. 198(1). 51–58. 90 indexed citations

15.

Noymer, Peter D., et al.. (2010). In Vitro Aerosol Deposition in the Oropharyngeal Region for Staccato ^® Loxapine. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23(4). 253–260. 24 indexed citations

16.

Noymer, Peter D., et al.. (2010). Assessing the Temperature of Thermally Generated Inhalation Aerosols. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 24(1). 11–15. 6 indexed citations

17.

Noymer, Peter D., et al.. (2010). In vitro aerosol characterization of Staccato® Loxapine. International Journal of Pharmaceutics. 403(1-2). 101–108. 36 indexed citations

18.

Elliott, Richard L., Robert M. Oliver, Marlys Hammond, et al.. (2003). Structure–activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(20). 3593–3596. 24 indexed citations

19.

Walker, David, James V. Cassella, Young-Lim Lee, Thereza Christina Monteiro de Lima, & Michael T. Davis. (1997). Opposing roles of the amygdala and dorsolateral periaqueductal gray in fear-potentiated startle. Neuroscience & Biobehavioral Reviews. 21(6). 743–753. 86 indexed citations

20.

Kehne, John H., James V. Cassella, George K. Aghajanian, John F. Tallman, & Michael T. Davis. (1987). Pertussis toxin or 8-bromo-cAMP block inhibition of the acoustic startle response by the α2-adrenergic agonist ST-91. Brain Research. 406(1-2). 87–92. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact